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ExerciseThe term reactive oxygen species (ROS) summarizes several small chemical compounds such as
superoxide, peroxynitrite, hydrogen peroxide and nitric oxide. The stoichiometry of the chemical reactions
underlying generation and metabolism is subject of tight enzymatic regulation resulting in well balanced
steady-state concentrations throughout the healthy body. ROS are short-lived and usually active at the site
of production only, e.g. in vascular endothelial cells. Although an increase of vascular ROS-production is
considered an important pathogenic factor in cardiovascular diseases, there is evidence for physiological or
even beneﬁcial effects as well. We have generated several transgenic mice using the Tie-2 promotor which
expresses an enzyme of interest speciﬁcally in vascular endothelial cells. Here, we review some results
obtained with mice carrying a Tie-2-driven overexpression of catalase or endothelial nitric oxide synthase
(eNOS). Tie-2-catalase mice have a strongly reduced steady-state concentration of vascular hydrogen
peroxide and show profound hypotension that is not dependent on the bioavailability of endothelial nitric
oxide but is completely reversible by treatment with the catalase inhibitor aminotriazole. A similar
hypotension was observed in transgenic mice with an endothelial-speciﬁc overexpression of eNOS but this
hypotension is entirely dependent on vascular eNOS activity. These observations suggest a tonic effect of
hydrogen peroxide on vascular smooth muscle. Further studies suggested that hydrogen peroxide promotes
the exercise-induced increase of vascular eNOS expression and inhibits the release of endothelial
progenitor cells induced by exercise training. In summary, our data support the concept of a dual role of
ROS in the vascular system.© 2009 Elsevier B.V. All rights reserved.1. Introduction
Reactive oxygen species generated in the vasculature are impor-
tant signaling molecules but act in a deleterious way as well [1].
Among the different cell types in vessels both endothelial cells and
smooth muscles cells are the source and the effectors of ROS at the
same time. Important molecules belonging to the group of vascular
ROS are nitric oxide (NO), superoxide, hydrogen peroxide, peroxyni-
trite and hydroxyl radicals (Fig. 1). Many different enzymes regulate
the homeostasis of vascular ROS. As for superoxide, NADPH-oxidases
existing in various subtypes in smooth muscle and endothelial cells
appear to be the most important generators [2], while three forms of
superoxide dismutases which convert superoxide to hydrogen
peroxide and oxygen can be viewed as hydrogen peroxide generators
[3]. Catalase and glutathione peroxydases regulate steady-state levels
of hydrogen peroxide by conversion to water [4]. Although there is aund Klinische Pharmakologie,
üsseldorf, Germany. Tel.: +49
).
ll rights reserved.general consent that NO produced by endothelial NO-synthase
(eNOS) is a rather beneﬁcial, i.e. vasoprotective, type of ROS [5],
some studies reported an impairment of endothelial function and
acceleration of atherosclerosis in transgenic mice with massive
overexpression of eNOS speciﬁcally targeted to vascular endothelial
cells [6,7]. The major reason for this appears to be a reaction between
NO and superoxide yielding peroxynitrite, an “ugly” metabolite of
NO [8]. Hydroxyl radicals are formed either by myeloperoxidase-
catalyzed or by Fe2+-catalyzed conversion of hydrogen peroxide and
are believed to accelerate atherosclerosis as well [1,9]. The aim of this
short review is to summarize data obtained from transgenic animals
which overexpress either eNOS or catalase speciﬁcally in vascular
endothelial cells. Studies with these mice have revealed some
signiﬁcant signaling events induced by vascular NO and hydrogen
peroxide in vivo.
2. Hydrogen peroxide
Hydrogen peroxide is non-radical uncharged oxidant which is
chemically more stable then other reactive oxygen species (ROS) and
can permeate through the vascular wall. Hydrogen peroxide produced
intracellularly can mediate local signaling by operating as a second
Fig. 1. Generation and metabolization of reactive oxygen species in the vasculature. Multiple enzymes may induce generation of superoxide (O2−U) including NADH/NADPH oxidase,
xanthine oxidase, lipoxygenase, cyclooxygenase, P-450 monooxygenase, and the enzymes of mitochondrial oxidative phosphorylation. Hydrogen peroxide (H2O2) is mainly formed
by 3 forms of superoxide dismutases (SOD) and rapidly degraded by catalase and glutathione peroxidase. Hydroxyl radicals (OH
U
) are formed either bymyeloperoxidase-catalyzed or
by Fe2+-catalyzed conversion of hydrogen peroxide. Nitric oxide (NO) produced by endothelial NO-synthase (eNOS) can react with superoxide yielding peroxynitrite (ONOO−).
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survive long enough to induce numerous paracrine functions, even in
more distant cells. While hydrogen peroxide is mainly formed by
superoxide dismutases, it is rapidly degraded by catalase and
glutathione peroxidase. In vivo, steady-state levels of hydrogen
peroxide in tissues and plasma are still unknown but are estimated
to be in the micromolar range [10,11].
A large number of reports have suggested that hydrogen
peroxide is an important mediator in the vasculature, e.g. a
regulator of smooth muscle hypertrophy and proliferation, of eNOS
expression and of arterial vasomotor tone [12–15]. However, in vitro
studies have yielded conﬂicting results on the effect of hydrogen
peroxide on vasomotor tone [16,17] suggesting that the vasomotor
response to hydrogen peroxide depends on experimental conditions
such as the type of vessel studied, the species studied and the
concentration range used. Furthermore, it is not clear whether
exogenous application of hydrogen peroxide is physiologically
relevant, and what concentration, dose or treatment duration
reﬂects the in vivo situation. To investigate the effect of endogenous
hydrogen peroxide on the vasomotor tone of resistance vessels in
vivo we generated transgenic mice with endothelial-speciﬁc over-
expression of human catalase.Fig. 2. Scheme of the construct inserted into fertilized eggs of C57BL/6 mice to generate mice
eNOS (bovine eNOS cDNA, 4.1 kb) driven by Tie-2 promotor (2.1 kb). Sal I restriction sites use
indicated. PCR primers used for genotyping PCR are indicated by horizontal arrows.2.1. Transgenic mice with endothelium-speciﬁc overexpression of
catalase
We used a transgenic construct, in which human catalase was
inserted between murine Tie-2 promotor (2.1 kb) and a 10 kb Tie-2
intron fragment, designated as Tie-2-enhancer and this construct was
used to target catalase gene expression to the vascular endothelium
(Fig. 2). In the original publication describing the discovery of the Tie-
2 promotor Schläger et al. suggested an endothelium-speciﬁc
expression induced by this promoter [18]. Our transgenic cat++
mice are the ﬁrst published mice where a mammalian gene (catalase)
was overexpressed using the Tie-2 promotor. The endothelium-
speciﬁc overexpression of catalase was evident in both conductance
and myocardial resistance vessels and associated with an increase of
catalase mRNA, protein and activity as well as a marked reduction of
the endothelial steady-state concentration of reactive oxygen species
including H2O2 [19,20]. Furthermore, endothelial speciﬁcity was
investigated bymeasuring dihydroethidine ﬂuorescence in leucocytes
by FACS analysis and no difference between catn and cat++ was found
suggesting absence of catalase overexpression in non-vascular cells
[19]. Since Tie-2 might be erexpressed in monocytes and neutrophils
[21,22] we have measured catalase protein expression in the bonewith endothelial-speciﬁc overexpression of catalase (human catalase cDNA, 1.7 kb) and
d for linearization of the plasmid and Sse83871/MluI sites added to cDNA for ligation are
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difference between the strains (our unpublished data). Taken
together, these data strongly suggest endothelial-speciﬁc overexpres-
sion of catalase in our transgenic cat++ mouse model.
2.1.1. Vascular effects of endothelial-speciﬁc overexpression of catalase
Our main ﬁnding is that a reduction of steady-state concentrations
of vascular hydrogen peroxide induced by an endothelial-speciﬁc
overexpression of human catalase resulted in a marked reduction of
systolic blood pressure in mice [19]. This hypotension was completely
reversible by the catalase inhibitor aminotriazole (Fig. 3A). In contrast,
Yang et al. reported that catalase overexpressing mice generated by
means of an 80-kb P1 clone containing the entire human catalase gene
show no change of hydrogen peroxide release from the aorta and have
normal blood pressure [23]. Thus, speciﬁc targeting of catalase
overexpression to the vasculature appears to be important to unmask
a vasotonic effect of endogenous hydrogen peroxide.
It has been shown that vascular hydrogen peroxide has many
associations to the vascular NO/cGMP pathway [12,14–17]. For
example, hydrogen peroxide may either enhance endogenous NO
generation by increasing the activity and expression of eNOS [24–26]
or impair endothelial production of NO in response to mediators such
as the calcium ionophore A23187, bradykinin and adenosine dipho-
sphate [27]. Hydrogen peroxide might also play a role in ﬂow-
mediated vasodilation and catalase likely consumes NO which
partially inhibits the enzyme's reaction with hydrogen peroxide
[28,29]. However, profound hypotension in our cat++ mice was notFig. 3. (A) Effects of NO-synthase inhibitor L-nitro-arginine (L-NA, 100 mg/kg BW/day)
and catalase inhibitor aminotriazole (670 mg/kg/day) on systolic blood pressure of cat
++ and catn. Measurements were obtained in resting awake animals using a tail-cuff
method (⁎Pb0.0001, One way ANOVA). Endothelial-speciﬁc overexpression of catalase
resulted in signiﬁcant reduction of systolic blood pressure in cat++ as compared to catn
and this difference remained after chronic inhibition of eNOS. In contrast, aminotriazole
treatment restored systolic blood pressure in cat++, but had no inﬂuence on blood
pressure in catn. (B) Effect of 3 weeks of exercise training (ex) on the aortic eNOS
protein expression in catn and cat++ as measured by western blot. In striking contrast
to control mice (catn), 3 weeks of exercise had no effect on vascular eNOS expression in
cat++ mice. Treatment of cat++ mice with the catalase inhibitor aminotriazole (ATZ)
restored exercise-induced aortic upregulation of eNOS.dependent on endogenous nitric oxide bioavailability (Fig. 3A). There
were no difference in vascular eNOS protein content, eNOS activity
and the efﬁciency of the NO/cGMP pathway between catn and cat++
mice as evidenced by western blot analysis, chronic treatment with
the NOS-inhibitor L-NAME and organ bath experiments, respectively.
These data do not support the hypothesis that endogenous hydrogen
peroxide impairs endogenous NO production and bioavailability in
blood pressure-regulating skeletal resistance vessels.
Organ bath experiments performed in aortric rings of catn and
cat++ mice revealed no difference in concentration-dependent
vasoconstriction to phenylephrine. However, inhibition of catalase
activity by aminotriazole unmasked a potentiation of adrenergic
vasoconstriction by phenylephrine in aortic rings of catn which was
attenuated in cat++, as expected. To investigate vasoconstrictor
effects of exogenous hydrogen peroxide, denuded aortic rings of catn
and cat++ were subjected to increasing concentrations of hydrogen
peroxide. Small vasoconstrictor effects were observed up to 50
μmol/L hydrogen peroxide in catn only, while higher concentrations
induced strong and irreversible vasodilator effects in catn and cat++.
These data suggest that concentrations of hydrogen peroxide which
likely resemble in vivo conditions induce vasoconstrictor effects in
aortic rings submaximally precontracted with phenylephrine. Thus,
endogenous hydrogen peroxide contributes to adrenergic vasocon-
striction in conductance vessels. Interactions of hydrogen peroxide
with some proteins of α1A/C-receptors signal transduction pathway
such as phospholipase C, protein kinase C and phosphoinositide 3-
kinase [30] might explain the molecular mechanisms underlying
hydrogen peroxide-induced increases of vascular tone.
The results of these organ bath experiments are consistent with
the observed change of systolic blood pressure, with the effects of
aminotrizole in vivo and with a previous report showing that
increases of blood pressure in response to vasoconstrictor agents
such as norepinephrine and angiotensin II were less pronounced in
mice with an unspeciﬁc overexpression of catalase [23]. Thus, the
involvement of endogenous hydrogen peroxide in adrenergic con-
striction of resistance vessels in vivo most likely contributes to
hypotension in cat++.
Hydrogen peroxide may contribute to pathologic events resulting
in hypertension. Experimental as well as clinical hypertension is
associated with oxidative stress [1,31]. Furthermore, previous studies
indicate that in hypertension the plasma concentration of hydrogen
peroxide is increased and is positively correlated to plasma renin
activity and systolic blood pressure, while negatively correlated to
cardiac contractility and renal function [10]. Yet, it is not known
whether vascular oxidative stress is a result of the disease or maybe
one underlying cause. Treatment options that have been shown to
reduce vascular oxidative stress also reduce blood pressure [1,31].
Thus, the direct demonstration of hypotension in mice carrying an
endothelial-speciﬁc overexpression of catalase strongly argues for
both, direct vasoconstrictor effects of endogenous hydrogen peroxide
on resistance vessels and a possible contribution of these effects to the
development of hypertension.
2.1.2. Role of endogenous hydrogen peroxide in exercise-induced
upregulation of eNOS
Previous studies have shown that hydrogen peroxide increases the
expression and activity of eNOS in endothelial cells [24,32,33]. The
increase of eNOS activity in response to hydrogen peroxide comes
along with a change of eNOS phosphorylation and is thought to be an
acute cellular adaptation to an increase in oxidant stress [25,26,34].
This is relevant to exercise, which is associated with an increase in
oxidative stress within the skeletal muscle and an increase in
circulating levels of H2O2 and markers of lipid oxidation. In vivo
studies in animals and humans have demonstrated that exercise
results in an increased vascular expression of eNOS suggesting an
important role of endogenous NO production for beneﬁcial effects of
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exercise training increases expression of vascular extracellular super-
oxide dismutase (ecSOD) which, in turn, facilitates the generation of
hydrogen peroxide from superoxide [36]. Using our transgenic mouse
model with endothelial-speciﬁc overexpression of catalase we
investigated whether endogenously produced hydrogen peroxide
contributes to the upregulation of eNOS expression induced by
exercise training.
Although vascular-speciﬁc overexpression of catalase had no effect
on basal expression of eNOS, it almost completely inhibited the
increase of eNOS expression induced by exercise in the aorta and in
left ventricular arterioles [20]. Furthermore, inhibition of the
artiﬁcially overexpressed catalase by oral treatment with catalase
inhibitor aminotriazole can rescue the physiologic upregulation of
endothelial eNOS expression induced by exercise (Fig. 3B). These
results strongly indicate that the activity of the overexpressed catalase
proteinwhich results in a strong reduction of the vascular steady-state
concentration of hydrogen peroxide is indeed responsible for the
dysfunctional eNOS-expression in response to exercise.
Regulation of vascular eNOS expression is a highly complex. Shear
stress is considered as an important stimulus for eNOS expression
[37]. Previous studies in endothelial cells have shown that hydrogen
peroxide increases eNOS expression as well [24]. The mechanism
underlying this upregulation includes a calcium-dependent increase
of calmodulin kinase II phosphorylation leading to activation of janus
kinase II [32]. The latter tyrosine kinase phosphorylates other protein
kinases such as Ras which directly activates transcription factors (for
review see [38]).
Previous studies have shown that c-Src plays a central role in
modulation of eNOS expression in response to shear stress via
divergent pathways involving a short-term increase in eNOS tran-
scription (c-Src activation of Ras/Raf and ERK1/2) and a longer-term
stabilization of eNOSmRNA [33]. Further studies showed that exercise
training increased eNOS protein N2-fold in the aorta and 1.7-fold in
the heart in C57Blk/6mice, but had no effect on eNOS protein levels in
c-Src+/− mice [34]. Taken together with our current data, it seems
that both vascular H2O2 and c-Src are critical in allowing endothelial
cells to increase eNOS expression during exercise training (Fig. 4). The
manner in which these signals interact in vivo are to be deﬁned.
A variety of studies have indicated that exercise is associated with
increased ATP synthesis in skeletal and myocardial muscle [39] and
we have found a more than 3-fold increase of citrate synthase activity,
which is known to correlate with training efﬁcacy [40]. During ATP
synthesis, the coenzyme Q radical can transfer its unpaired electron to
molecular oxygen which increases superoxide and subsequently theFig. 4. Summary of the effects of exercise on endothelial-speciﬁc expression of endothelial NO
exercise is the increase of heart rate and of blood pressure. This induces an increase of physi
shown to increase oxidative stress [42] and to induce eNOS expression and phosphorylation
been shown in cell culture experiments to induce eNOS expression as well. Overexpression o
citation numbers).generation of hydrogen peroxide [41]. Thus, mitochondrial hydrogen
peroxide may contribute to increased vascular oxidative stress during
exercise, particularly in myocardial and skeletal muscle arterioles
where the diffusion distance is comparatively small. Furthermore,
exercise increases heart rate and this will almost certainly enhance the
mechanical forces of blood ﬂow such as shear stress, pressure and
cyclic strain on the vascular wall [35] and shear stress has been shown
to increase endothelial superoxide generation [42]. Further studies
have identiﬁed the endothelial NADPH oxidase as a major source of
vascular superoxide induced by laminar and oscillatory shear [43]. In
addition, shear stress is a potent stimulus for the expression of
endothelial cell Cu/Zn SOD [44]. Thus, superoxide generated during
exercise training may be more readily dismutated to hydrogen
peroxide.
Our ﬁndings may have implications for the use of antioxidants and
drugs that suppress the production of reactive oxygen species in vivo.
While reactive oxygen species produced in large quantities clearly
mediate cellular damage, lower levels of reactive oxygen species may
have important signaling properties [45]. Therefore, suppression of
cellular production of reactive oxygen species might lead to a loss of
important vascular signaling events as is the case illustrated in this
study: an inability to increase eNOS in response to exercise training
which, over the long run, presumably increase the antioxidative capacity
of the vascular wall and protect the vasculature against permanent
oxidative stress known to be present in cardiovascular disease.
2.1.3. Role of endogenous hydrogen peroxide in cardiovascular
ischemia–reperfusion injury
It is well known that myocardial ischemia–reperfusion depresses
myocardial function and causes deleterious morphological changes
that lead to heart failure and cardiac cell death [46,47]. Several reports
suggest that increased oxidative stress and burst of free radical
production including hydrogen peroxide are important mediators of
myocardial ischemic damage [48,49]. However, most of the studies on
the role of catalase and hydrogen peroxide in myocardial ischemia–
reperfusion are performed with in vivo supplementation of catalase
by injection or in vitro addition of hydrogen peroxide or catalase to
perfusion buffers. Data interpretation from these studies is limited,
since the physiologically relevance of such in vitro experiments are for
the most part unclear. Using our transgenic animals we have
investigated whether endogenous hydrogen peroxide produced in
the vasculature is involved in ischemia–reperfusion injury. We
hypothesized that endothelial-speciﬁc overexpression of catalase
might improve coronary or/and myocardial reperfusion function via
protection during ischemia and reperfusion. These processes are-synthase. One of themost important changes within the cardiovascular systems during
cal forces such as shear stress and an increase of oxidative stress. Shear stress has been
[37,76]. Oxidative stress results in increased formation of hydrogen peroxide which has
f catalase blunts the effect of exercise on eNOS expression (numbers in brackets indicate
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lial-speciﬁc overexpression of catalase had only little effects on
myocardial contractility, coronary function or electrical stability in
hearts subjected to 20 min of global ischemia followed by 30 min of
reperfusion [51]. However, hearts from cat++ mice subjected to
ischemia–reperfusion showed better inotropic and lusitropic
responses to exogenous norepinephrine, suggesting that hydrogen
peroxide is involved in oxidant-mediated ischemia–perfusion injury.
Thus, overexpression of catalase in the endothelium is only weakly
protective against myocardial ischemia–reperfusion injury, but
appears to preserve the responsiveness of the heart to adrenergic
stimulation.
2.1.4. Role of endogenous hydrogen peroxide in exercise-induced increase
of circulating stem cells with endothelial progenitor capacity
Vascular oxidative stress has been shown to promote many
pathophysiologic changes resulting in cardiovascular remodeling
underlying cardiovascular diseases [1]. Recent evidence suggest that
regeneration of damaged vascular endothelium involves the participa-
tion of stem cells mobilized from the bone marrow. Asahara et al. ﬁrst
published that circulating CD34+-angioblasts within human periph-
eral blood are able to differentiate in vitro to endothelial phenotype
[52]. These cells were named “endothelial progenitor cells (EPCs)”.
EPCs participate in endothelial homeostasis by contribution to re-
endothelialization and improve organ blood ﬂow by homing into
ischemic regions and forming entirely new vessels or by releasing
angiogenic factors in a paracrine manner [53–55]. These beneﬁcial
effects are impaired when the number and/or functional activities of
EPCs are reduced. Clinical trials revealed that the number of circulating
EPCs is decreased in subjects with cardiovascular risk factors, such as
such as hypercholesterolemia, diabetes and smoking [56] and a similar
situation likely holds true for EPC homing [57]. Since these pathologies
are all associated with increased vascular oxidative stress, depletion of
circulating EPCs is considered a marker of the progression of
cardiovascular disease [58]. Whether oxidant damage directly affects
EPC mobilization is an important, but unanswered question.
It is well known that the effect of reactive oxygen species on
vascular function is critically concentration-dependent. Under phy-
siological conditions, i.e. at lowconcentrations, reactive oxygen species
can act as intracellular second messenger, modulating proangiogenic
pathways such as VEGF-A signaling and postnatal vasculogenesis [59],
while higher concentrations of reactive oxygen species, e.g in
cardiovascular disease, likely impairs vessel growth. Therefore,
reactive oxygen species may directly inﬂuence stem cell-induced
vascular repair mechanisms by reducing the number of circulating
EPCs.
We investigated the effect of hydrogen peroxide on the number of
circulating EPCs in sedentary C57Bl/6, catn and cat++ mice. We have
trained catn and cat ++ using different training protocols andmethods
and measured peripheral EPCs levels. The major ﬁndings are that
exercise apparently doesn't change circulating EPCs in young healthy
C57Bl/6 mice [60]. In striking contrast, exercise strongly increased
EPCs in cat++-mice and this was completely inhibited by oral
treatment with the catalase inhibitor aminotriazole. Likewise, inhibi-
tion of catalase by oral aminotriazole strongly decreased circulating
EPCs in both catn and cat++-mice independent of exercise. These
data suggest a new pathophysiologic role of hydrogen peroxide as one
player of vascular oxidative stress, i.e. a reduction of the number of
circulating EPCs.
3. Nitric oxide
3.1. Transgenic mice with endothelial-speciﬁc overexpression of eNOS
Nitric oxide derived from eNOS, a major isoform of NOS in the
cardiovascular system has a highly diverse biological proﬁle includingvasodilation, antiaggregation, antiapoptosis, antiantiadhesion, anti-
proliferation and antioxidation [5]. In vivo studies of eNOS using
murine knockout models have provided the wealth of information
regarding the role of eNOS in cardiovascular physiology and disease.
However, genetic approach not only provided new insight into the
actual role of eNOS, but also uncovered possible secondary alterations
which compensate for the induced change. In the case of eNOS
knockout mice, upregulation of other NOS isoforms, induction of
signal molecules such as prostaglandins or endothelium-derived
hyperpolarizing factor may compensate for the lack of eNOS.
Along with existing complementary knockout models, transgenic
mouse models overexpressing eNOS provided important ﬁndings
regarding the crucial role of eNOS in preventing cardiovascular septic
shock, regulating blood pressure and modulating the baroreceptor
response [61] and highlighted the complexity of eNOS regulation.
Here, we describe the existingmousemodels for eNOS overexpression
and compare them to our recently generated mouse transgenic line
with endothelial-speciﬁc overexpression of bovine wild type eNOS
driven by murine Tie-2 promotor.
3.1.1. Existing mouse models for eNOS overexpression
The ﬁrst transgenic mouse model overexpressing bovine eNOS in
the vascular wall was generated by Ohashi et al. using murine
preproendothelin-1 promotor [7]. Targeting the transgene to the
endothelium resulted in exogenous bovine eNOS mRNA and protein
expression in endothelium of the thoracic aorta, large pulmonary
arteries and medium to small sized coronary arteries. These eNOS++
mice have hypotension which was completely reversed by chronic L-
NAME treatment suggesting NO-mediated reduction of blood pres-
sure. Furthermore, eNOS++ mice showed signiﬁcantly decreased
aortic endothelial-dependent relaxation and depressed vascular
responses to exogenous NO. Decreased soluble guanylyl cyclase
activity and cGMP-dependent protein kinase levels have been
suggested as a mechanism for impaired endothelial-dependent
relaxation [62]. Further studies on importance of eNOS cofactor
tetrohydrobiopterin (BH4) in regulating eNOS activity revealed that
eNOS-derived superoxide production is enhanced in eNOS++ mice in
cardiac tissue lysates and intact aorta indicating increased eNOS
ucoupling in these animals [63]. In accordance with having increased
uncoupled eNOS and depleted BH4 levels, speciﬁc eNOS enzymatic
activity was markedly attenuated in eNOS++ (elevated only 2-fold
compared with wild type) relative to eNOS protein levels (elevated 8-
fold compared with wild type). The authors concluded that eNOS
uncoupling in eNOS++ mice is an independent and direct conse-
quence of a stoichiometric discordance between enzyme and its
cofactor BH4.
Another group has generated a mouse model overexpressing
human eNOS gene [64] by a random insertion of the human eNOS
DNA fragment and the native eNOS promotor that contains all the
regulatory sequences of eNOS. Mice overexpressing eNOS were
hypotensive and had a 20% lower systemic vascular resistance which
was sensitive to administration of NOS-inhibitor L-NAME. Immuno-
histochemistry revealed eNOS localisation in the endothelial cells of
smaller and larger blood vessels of several organs (aorta, heart,
kidney). eNOS protein level was tremendously increased as evident by
western blot analysis and was accompanied by a 10-fold increase in
NOS activity measured by the L-arginine to L-citrulline conversion
assay in aortic tissue homogenates. Furthermore, studies of integrated
systemic resistance using isofurane-anesthetized open-chest mouse
model showed a decreased responsiveness of soluble guanylyl cyclase
(sGC) to exogenousNOand lower sGC activity, but no evidenceof eNOS
uncoupling or adaptation in other vasoregulatory pathways [65].
It is well known that impairment or deﬁciency of eNOS gives rise to
accelerated atherosclerosis indicating that physiological levels of
eNOS are anti-atherogenic [66]. Two strains of eNOS overexpressing
mice have been bredwith apolipoprotein E-deﬁcientmice to study the
Fig. 5. (A) Representative ﬂuorescent immunohistochemical image performed in
carotid artery of eNOS++ mice double stained for eNOS (green) and for the endothelial
marker CD31 (red). Nuclei are stained blue. Original magniﬁcation: 200×. (B) Reduced
blood pressure in eNOS ++ mice was completely dependent on eNOS activity as
evidenced by oral treatment with L-nitro-arginine which increased the blood pressure
to a similar degree in eNOSn and eNOS++ mice. Termination of L- nitro-arginine
treatment induced a complete restoration of systolic blood pressure to pretreatment
values in both strains.
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have been reported.When eNOS++mice generated by van Haperen et
al. were crossbred with Apo E knockouts and fed with “western-type”
diet, atherosclerotic lesion size was signiﬁcantly reduced by eNOS
overexpression. As for the underlying mechanisms, reduction in blood
pressure and 15% lower plasma cholesterol levels in eNOS++ mice
were suggested. The authors conclude that elevation of eNOS activity
could be beneﬁcial for patients at risk of developing atherosclerotic
disease [64].
In striking contrast, Ozaki et al. reported that atherosclerotic
lesions areas were signiﬁcantly larger in Apo E/eNOS++ mice then in
Apo E knockouts both fed with “high-cholesterol” diet [6]. They have
found the presence of eNOS dysfunction, demonstrated by lower NO
production relative to eNOS protein levels. This was associated with
increased superoxide production and decreased vascular BH4 levels
suggesting that chronic overexpression of eNOS does not inhibit, but
accelerates atherosclerosis under hypercholesterolemia. Several
potential mechanisms might explain the difference between the
outcomes of these studies. First, the difference in promoter by which
eNOS was targeted resulted in different expression levels of eNOS.
Second, this discrepancy may be due to the difference between “high-
cholesterol” and “western style” diets used to promote atherosclerosis
and therefore due to the difference in balance between NO and
superoxide production from the endothelium. Finally, it appears that
eNOS++ mice generated by Ohashi et al. overexpressed uncoupled
eNOS as a consequence of a stoichiometric discordance between
enzyme and its cofactor BH4 [67].
3.1.2. Mice with endothelial-speciﬁc overexpression of eNOS driven by
Tie-2 promotor
Recently we have generated a mouse model in which bovine eNOS
was inserted betweenmurine Tie-2 promotor and a 10 kb Tie-2 intron
fragment, designated as Tie-2-enhancer (Fig. 2). In agreement with
the original publication of Tie-2 promotor [18] and our previous
studies [19,20], ﬂuorescent immunohistochemistry revealed an
endothelial-speciﬁc eNOS overexpression in coronary arterioles and
in carotid artery of eNOS++ mice (Fig. 5A). Western blot and
densitometric analysis detecting eNOS protein in mouse aorta showed
3.2-fold overexpression in eNOS++. The overexpressed eNOS protein
was functionally active as indicated by a signiﬁcant reduction of blood
pressure (∼15 mm Hg) in eNOS++ as compared to transgen-negative
littermates. Furthermore, the reduction of blood pressure was
completely blunted by oral treatment with the NOS-inhibitor L-NA
(Fig. 5B). Electron spin resonance measurements with Fe2+(DETC)2
(iron/diethyldithiocarbamic acid, 0.2 mmol/L) spintrap revealed an
increased concentration of nitric oxide in the aorta of eNOS++ (Fig. 6).
Using the CPH (1-hydroxy-3-carboxy-2,2,5,5-tetramethylpyrroli-
dine) spintrap, neither an increase of oxidative stress nor an increase
of peroxynitrite concentration was detected in eNOS++ heart tissue.
Similar results were obtained in aortic, muscle and lung tissues (our
unpublished data). An important advantage of our transgenicmodel is
relatively moderate level of eNOS overexpression which is sufﬁciently
low to avoid increased OONO− generation. The higher the expression
strength is, the more peroxynitrite appears to be generated as
predictable from the law of mass action. The reaction constant for
the reaction of NO with superoxide is about 3 times higher
(1.9×1010 M−1 s−1) than the reaction constant for the reaction of
superoxide with SOD (2.4×109 M−1 s−1) [5]. It is assumed that
generation of OONO− is outcompeted by the 100–1000-fold higher
concentration of SOD as compared to NO. The higher the steady-state
concentration of NO the higher is the possibility of OONO−
generation. In our mind, this advantage of our model enables us to
investigate in vivo NO-physiology rather than in vivo NO-toxicology.
3.1.2.1. Inﬂuence of eNOS overexpression on vascular soluble guanylyl
cyclase (sGC) in vivo. In contrast to the results of Yamashita et al.endothelium-dependent vasodilation induced by acetylcholine in
aortic rings of our eNOS++ mice was not altered. Furthermore,
overexpression of eNOS did not lead to a signiﬁcant rightward shift of
the relaxation response to the NO-donor SNAP suggesting no changes
in vascular sensitivity to exogenous NO. Moreover, endothelial-
speciﬁc overexpression of eNOS did not change the protein expression
of sGC-α1 and sGC-β1 subunits In contrast, we have found a strong
decrease in maximal sGC activity in eNOS overexpressing mice and
phosphorylation of VASP at serine 239, which is characteristic for
cGMP-dependent phosphorylation was signiﬁcantly decreased in
eNOS++ mice [68].
These data suggest that NO does not regulate sGC expression in
vivo and that even marked reductions of sGC activity do not translate
into a functional impairment of the vascular NO/cGMP pathway. No
changes of sCG expression by endogenous chronically elevated nitric
oxide production are in agreement with our recently published study
showing no effect of therapeutic treatment with long-acting NO-
donor PETN and ISMN on the expression and function of vascular sGC
in vivo [69]. Furthermore, other report failed to show the existence of
a NO-dependent feed-back loop controlling sGC expression in vivo
[62]. Mice overexpressing eNOS in the vasculature driven by
preproendothelin-1 promotor showed a resistance to endothelium-
dependent and NO-induced vasodilatation but not a decrease of sGC
expression [62]. Instead, the authors describe a 50% reduction of basal
unstimulated sGC activity and a 20% reduction of PKG expression.
Reduced activity of sGC in the peripheral resistance vessels, but not in
aorta, was also reported in another mouse model overexpressing
eNOS, although signal transduction pathway downstream was
unaffected by eNOS overexpression in these mice [65]. Other groups
reported that changes of PKG activity do not occur in eNOS knockout
Fig. 6. Summary of the effects of endothelial-speciﬁc overexpression of catalase and endothelial NO-synthase driven by the Tie-2 promotor.
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animal model [70,71].
The results of our experiments indicate that the NO-cGMP
pathway has a great capacity which ensures full functional activity
even in the setting of strong desensitization of the central enzyme
sGC. These results are in line with a recent report demonstrating that
the majority of NO-sensitive sGC is not required for cGMP-forming
activity [72]. In this investigation, a complete NO-dependent vasodila-
tion was achieved in aortic rings of sGC-α1 deﬁcient mice. This
vasodilation occurred despite a low increase in vascular cGMP andwas
mediated by the sGCα2/sGC-β1 heterodimer which accounts for only
6% of total vascular sGC.
In summary, our results refute the hypothesis that therapeutic [69]
and endogenous NO play a signiﬁcant role in regulation of vascular
sGC protein expression. Feed-back signaling by NO of vascular sGC
expression did not occur in vivo, not even at continuous NO-
concentrations inducing a strong reduction of blood pressure.
3.1.2.2. Antioxidative effects of eNOS overexpression. It is generally
accepted that endothelial dysfunction is a consequence of increased
vascular oxidative stress, a condition characterized by a misbalance
of endogenous production of vascular ROS and the vascular
antioxidative capacity. Although a variety of mediators have been
described to contribute to vascular oxidative stress, both the
generation and detoxiﬁcation of superoxide most likely play a
major role in this process. Superoxide is generated by physiologic
reactions as a metabolic by-product, for example in mitochondria,
by CYP-oxygenases, by xanthine oxidase, by nitric oxide synthases
and particularly by NAD(P)H-oxidases [13] (Fig. 1). There are
highly speciﬁc mechanisms to rapidly detoxify superoxide and
thereby prevent unwanted oxidatative processes in cells andtissues. Of these, the superoxide dismutases I (CuZnSOD), II
(MnSOD) and III (extracellular (ec)SOD) are of utmost importance.
While CuZnSOD and MnSOD provide intracellular and intramito-
chondrial protection against superoxide, respectively, ecSOD does
so in the interstitium. It is expressed in vascular smooth muscle
cells and consecutively secreted to the interstitium [73]. It rapidly
binds to polyanionic sites such as heparan sulfates at the outer
membrane of endothelial cells and protects endothelial NO while it
traverses to the smooth muscle cell layer of the vascular wall [74].
In fact, the highest ecSOD concentrations can be found between
the endothelial cell layer and the smooth muscle and 99% of ecSOD
is tissue-bound.
Our previous investigations have shown that endogenous NO is an
essential stimulus of ecSOD expression in large conductive vessels
such as the aorta and that an increase of eNOS expression by exercise
results in a consecutive overexpression of ecSOD [36]. Hence, driving
the expression of ecSOD appears to be an important mechanism
underlying the antioxidative effects of NO. Therefore we investigated
whether endothelial-speciﬁc overexpression of eNOS and increase of
endogenous NO levels inﬂuence ecSOD expression and activity in the
microvasculature.
We found a signiﬁcant upregulation of ecSOD protein expression
and activity in lung cytosols of eNOS++ mice suggesting that NO is
the active mediator [75]. To further challenge this hypothesis, we
treated both eNOSn and eNOS++ mice with the NOS-inhibitor L-NA
and observed a strong downregulation of ecSOD protein expression.
This result provides additional evidence for a regulatory role of
vascular NO for ecSOD protein expression. Likewise, this result
demonstrates that the increase of ecSOD in eNOS++ is not an
unspeciﬁc consequence of genetic manipulation. Similar increase in
the expression and activity of microvascular and macrovascular
809T. Suvorava, G. Kojda / Biochimica et Biophysica Acta 1787 (2009) 802–810ecSOD in vivo was observed in mice treated with the organic nitrate
PETN, further suggesting that an increased bioavailability of vascular
NO is the underlying cause [75].
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